Company intelligence / Profile preview

Quanterix

Billerica, Massachusetts, United Statesquanterix.com ↗

Ownership: Public · QTRX
Employees: ~471
Development stage: Commercial

Overview

Quanterix has commercialized ultra-sensitive digital immunoassay platforms for research and clinical use. Its Simoa-based assays enable detection of over 150 protein biomarkers at extremely low concentrations in blood and other fluids. The company has launched the first assay to reliably measure NfL in blood—a key biomarker for neurodegeneration—and continues to expand its menu with new diagnostic tests such as LucentAD for Alzheimer’s disease. The company does not develop therapeutics but provides enabling technologies that support biomarker discovery and validation across preclinical through clinical stages.

Therapeutic areas: CardiovascularImmunologyOncologyNeurologyInfectious Diseases
Modalities: DeviceDiagnostic platformImmunoassay
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborates with major pharmaceutical companies and academic institutions globally to drive adoption of Simoa technology; specific partners not named in provided results but includes leading pharma/biotech firms.

Financials

Market cap: $124.8M
Total revenue: $32.9M
Enterprise value: $64.7M

Beyond the preview

Go deeper on Quanterix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quanterix.

Explore the full profile